DexCom, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $836.3M | $576.2M | $541.5M | $341.2M | $216.9M | $549.7M | $101.1M | $-127.1M |
| Depreciation & Amortization | $251.8M | $217.7M | $186.0M | $155.9M | $102.0M | $67.1M | $48.7M | $29.1M |
| Depreciation | $219.0M | $181.2M | $147.4M | $144.1M | $96.3M | $64.0M | $46.9M | $28.6M |
| Amortization | $4.2M | $6.7M | $8.1M | $7.5M | $3.7M | $2.5M | — | — |
| Stock-Based Compensation | $159.6M | $170.4M | $150.8M | $126.5M | $113.4M | $119.4M | $102.7M | $101.9M |
| Net Cash from Operating Activities | $1.44B | $989.5M | $748.5M | $669.5M | $442.5M | $475.6M | $314.5M | $123.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $363.5M | $358.8M | $236.6M | $364.8M | $389.2M | $199.0M | $180.0M | $67.1M |
| Business Acquisitions | — | $0 | $0 | $3.9M | $30.2M | $0 | $0 | $11.3M |
| Net Cash from Investing Activities | $536.0M | $-207.5M | $-507.2M | $-521.5M | $-216.1M | $-1.02B | $-1.02B | $-139.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $500.0M | $750.0M | $688.7M | $557.7M | $0 | $0 | $0 | $100.0M |
| Net Cash from Financing Activities | $-1.69B | $-734.8M | $-318.6M | $-552.5M | $10.4M | $912.1M | $10.7M | $710.4M |
| Net Change in Cash | $311.8M | $39.8M | $-75.8M | $-410.3M | $235.4M | $371.8M | $-690.7M | $695.6M |
| Free Cash Flow | $1.08B | $630.7M | $511.9M | $304.7M | $53.3M | $276.6M | $134.5M | $56.1M |